FOS and breast carcinoma: 5d). Similar results were also obtained from MDA-MB-231 breast cancer cells with endogenous FGFR1 expression, where c-FOS recruitment to the FOXQ1 gene promoter was increased about two folds upon bFGF treatment (Fig.